or Try an Advanced Search...

    Small Molecule Therapies Stocks List

    Symbol Grade Name % Change
    NRIX C Nurix Therapeutics, Inc. -3.14
    EWTX C Edgewise Therapeutics, Inc. 2.83
    IVA D Inventiva S.A. -2.34
    PRLD D Prelude Therapeutics Incorporated 7.00
    CTNM D Contineum Therapeutics, Inc. -2.29
    EXEL F Exelixis, Inc. 0.52
    APTO F Aptose Biosciences, Inc. 0.84
    RAPT F RAPT Therapeutics, Inc. -2.47
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Cancer Biotechnology Treatment Of Cancer Disease Life Sciences Lymphoma Phosphoinositide 3 Kinase Inhibitor Protein Kinase Inhibitor Solid Tumors Tyrosine Kinase Acute Myeloid Leukemia Alcohol Bacterial Infections Bemcentinib Biology Blastoma Bruton's Tyrosine Kinase Cancer Therapies Clinical Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Small Molecule Therapies stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.47
    IDNA B iShares Genomics Immunology and Healthcare ETF 4.31
    FBT C First Trust Amex Biotech Index Fund 3.13
    PBE B PowerShares Dynamic Biotech & Genome 2.87
    ARKG D ARK Genomic Revolution Multi-Sector ETF 2.48
    View all Small Molecule Therapies ETFs...
    Compare ETFs
    Compare CNCR to IDNA Compare CNCR to PBE Compare IDNA to PBE

        Small Molecule Therapies Stocks Recent News

        Date Stock Title
        May 16 IVA Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
        May 15 APTO Aptose Biosciences Inc. (APTO) Q1 2024 Earnings Call Transcript
        May 14 APTO Aptose Biosciences GAAP EPS of -$0.73 beats by $0.09
        May 14 APTO Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses
        May 14 APTO Aptose Reports Results for the First Quarter 2024
        May 14 RAPT Wolfe downgrades RAPT, but still sees "immense" upside potential
        May 14 NRIX Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)
        May 13 IVA Why Is Inventiva's Stock Trading Higher on Monday?
        May 13 RAPT Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
        May 13 IVA Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor
        May 12 EXEL Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
        May 12 RAPT Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
        May 11 EXEL Exelixis files patent suit against India’s Cipla over Cabometyx generics
        May 10 RAPT RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
        May 10 EWTX Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run
        May 10 EWTX Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
        May 10 RAPT RAPT falls for second day as Guggenheim, Barclays downgrade stock
        May 10 EWTX Edgewise Therapeutics files mixed securities shelf
        May 10 EWTX Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Cancer Biotechnology Treatment Of Cancer Disease Life Sciences Lymphoma Phosphoinositide 3 Kinase Inhibitor Protein Kinase Inhibitor Solid Tumors Tyrosine Kinase Acute Myeloid Leukemia Alcohol Bacterial Infections Bemcentinib Biology Blastoma Bruton's Tyrosine Kinase Cancer Therapies Clinical Medicine
        Small Molecule Therapies

        Small molecule therapies are drugs that are designed to target specific molecules in the body, such as proteins, enzymes, or receptors. These drugs are typically small molecules that can be easily absorbed and distributed throughout the body. They are used to treat a variety of diseases, including cancer, heart disease, and neurological disorders.

        Browse All Tags